Dupilumab (anti-IL-4Rα)

Catalog No.A2038 Synonyms: Dupixent, REGN-668, SAR-231893

For research use only.
Not for use in humans.

Dupilumab (anti-IL-4Rα) (Dupixent, REGN-668, SAR-231893) is a fully human anti–interleukin-4 receptor α monoclonal antibody that inhibits both interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling through blockade of the shared IL-4α subunit.

Dupilumab (anti-IL-4Rα)

Purity & Quality Control

Choose Selective Interleukins Inhibitors

Biological Activity

Description Dupilumab (anti-IL-4Rα) (Dupixent, REGN-668, SAR-231893) is a fully human anti–interleukin-4 receptor α monoclonal antibody that inhibits both interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling through blockade of the shared IL-4α subunit.

Protocol (from reference)

Product Details

CAS No. 1190264-60-8
Molecular Weight 147 KD
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4, κ
Source CHO cells
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dupilumab (anti-IL-4Rα) | Dupilumab (anti-IL-4Rα) supplier | purchase Dupilumab (anti-IL-4Rα) | Dupilumab (anti-IL-4Rα) cost | Dupilumab (anti-IL-4Rα) manufacturer | order Dupilumab (anti-IL-4Rα) | Dupilumab (anti-IL-4Rα) distributor